<p>Analysis of the Financial Impact of Using Cangrelor on the Safety and Efficacy Outcomes in Patients Undergoing Percutaneous Coronary Intervention in Whom Oral Therapy with P2Y<sub>12</sub> Inhibitors is Not Feasible or Desirable, in Spain</p>

Original Research

Analysis of the Financial Impact of Using Cangrelor on the Safety and Efficacy Outcomes in Patients Undergoing Percutaneous Coronary Intervention in Whom Oral Therapy with P2Y₁₂ Inhibitors is Not Feasible or Desirable, in Spain

Total article views		HTML views	PDF downloads	Totals
8,061	Dovepress*	7,332+	699	8,031
	PubMed Central*	729	140	869
	Totals	8,061	839	8,900
*Since 27 January 2021

Total mentioned	Facebook	Delicious	Reddit	Twitter	Others
2	0	0	0	1	1